STAT June 4, 2024
Good morning, and welcome to STAT’s live blog of the Food and Drug Administration’s scientific advisory committee meeting to review safety and efficacy data for MDMA-assisted psychotherapy to treat post-traumatic stress disorder. The discussion will start at 8:30 a.m. ET and run until about 5:30 p.m. (here’s an agenda). We published an in-depth story on Friday about what to expect today, but here are the basics:
MDMA is the first Schedule I psychedelic to be considered by the FDA — meaning that,...
Today's Sponsors
Today's Sponsor